US20030120348A1 - Artificial bone graft implant - Google Patents
Artificial bone graft implant Download PDFInfo
- Publication number
- US20030120348A1 US20030120348A1 US10/353,533 US35353303A US2003120348A1 US 20030120348 A1 US20030120348 A1 US 20030120348A1 US 35353303 A US35353303 A US 35353303A US 2003120348 A1 US2003120348 A1 US 2003120348A1
- Authority
- US
- United States
- Prior art keywords
- implant
- bone
- pore size
- center portion
- outer portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/4455—Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2825—Femur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2835—Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30011—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in porosity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30112—Rounded shapes, e.g. with rounded corners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30112—Rounded shapes, e.g. with rounded corners
- A61F2002/30125—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30138—Convex polygonal shapes
- A61F2002/30153—Convex polygonal shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30138—Convex polygonal shapes
- A61F2002/30158—Convex polygonal shapes trapezoidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30182—Other shapes
- A61F2002/30187—D-shaped or half-disc-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30721—Accessories
- A61F2002/30733—Inserts placed into an endoprosthetic cavity, e.g. for modifying a material property
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30772—Apertures or holes, e.g. of circular cross section
- A61F2002/30777—Oblong apertures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30772—Apertures or holes, e.g. of circular cross section
- A61F2002/30784—Plurality of holes
- A61F2002/30785—Plurality of holes parallel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30968—Sintering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0008—Rounded shapes, e.g. with rounded corners elliptical or oval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0019—Angular shapes rectangular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0026—Angular shapes trapezoidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0034—D-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0023—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00329—Glasses, e.g. bioglass
Definitions
- the present invention relates to artificial bone graph implants and more specifically to artificial bone graft implants constructed so as to allow bone ingrowth while maintaining a load-bearing strength similar to natural bone.
- bone grafts are used as part of the surgical procedure.
- bone grafts are used in facial reconstruction, in repairing long bone defects, and in spinal surgery such as intervertebral discectomy and fusion in which a bone graft implant replaces a spinal disc in the intervertebral space.
- Bone used for bone graft implants is often removed from another portion of a patient's body, which is called an autograft.
- a significant advantage of using a patient's own bone is the avoidance of tissue rejection, but harvesting bone also has its shortcomings.
- the bone harvesting site is weakened by the removal of the bone.
- the bone graft implant may not be perfectly shaped which can cause misplacement of the implant. This can lead to slippage or absorption of the implant, or failure of the implant to fuse with the bone it is in contact with.
- bone graft source is bone removed from cadavers, called allograft, or from an animal, called xenograft. While these kinds of bone grafts relieve the patient of having a secondary surgical site as a possible source of infection or pain, this option carries a high incidence of graft rejection and an increased risk of the transmission of communicable diseases.
- An alternative to using living bone graft implants is the use of a manufactured implant made of a synthetic material that is biologically compatible with the body.
- a manufactured implant made of a synthetic material that is biologically compatible with the body.
- several synthetic compositions and various geometries of such implants have been utilized.
- the implanting surgery of such implants is accomplished without difficulty, but the results can be unsatisfactory because any minor dents or imperfections in the implant can cause poor bone-to-implant bonding or an implant having a very high porosity can collapse due to lack of mechanical strength.
- the artificial implant requires a complex surgical procedure that is difficult to perform and may not lead Co correction of the problem again, because of the above discussed side effects or dislocation of the artificial implant.
- no fully satisfactory artificial implant is known that can be implanted with a relatively straightforward procedure.
- HAp Hydroxylapatite
- an artificial bone graft implant that is formed of a biocompatible mineral material similar to bone which possesses compressive strength close to that of natural bone while providing for in growth of bone tissue for permanent fixation.
- the present invention provides an artificial bone graft implant formed of a biocompatible mineral material which possesses compressive strength similar to that of natural bone and allows bone tissue ingrowth for permanent fixations.
- the artificial bone graft implant is used as a replacement for living bone material in surgical procedures requiring the use of bone graft material.
- the inventive implant has a body configured to be implanted into a prepared site in a patient's bone tissue, with the body having a pair of opposed outer surfaces defining the body.
- a first and a second porous portion form the body with the first and second porous portions having pores of different sizes such that time average pore size of the first porous portion is greater than the average pore size of the second porous portion.
- the first porous portion of the body is formed in the shape of a core, with the core being in contact with the opposed outer surfaces of the body, and the second porous portion of the body is formed in the shape of an outer shell.
- the pore size of the first porous portion of the implant allows for the ingrowth of bone tissue while the pore size of the second portion of the implant allows for a load bearing capacity similar to natural bone.
- the unique hybrid structure of a dense outer shell and a porous core provides load bearing support while simultaneously allowing bone ingrowth.
- the implant of the invention may be readily implanted by established surgical procedures, with minimal need to alter known surgical procedures.
- the hybrid porous/dense construction of the implant ensures normal load bearing and support through the eventual ingrowth of bone tissue, and minimizes the likelihood of implant dislocation relative to adjacent bone tissue either during surgery or during the post-operative fusion process.
- FIG. 1 is a perspective view of the present invention in the form of a spinal disc implant
- FIG. 1A is a plan view of the posterior end of the implant of FIG. 1 taken along lines 1 A- 1 A;
- FIG. 1B is a cross sectional view of the implant of FIG. 1 taken along lines 1 B- 1 B in FIG. 1A;
- FIG. 1C is a cross sectional view of the implant of FIG. 1A; taken along lines 1 C- 1 C in FIG. 1;
- FIG. 1D is a cross sectional view of the implant of FIG. 1 taken along lines 1 D- 1 D in FIG. 1A;
- FIG. 2 is a perspective view of the present invention in the form of a femoral ring implant
- FIG. 2A is a plan view of the posterior end of the implant of FIG. 2 taken along lines 2 A- 2 A;
- FIG. 2B is a cross sectional view of the implant of FIG. 2 taken along lines 2 B- 2 B in FIG. 2A;
- FIG. 2C is a cross sectional view of the implant of FIG. 2 taken along lines 2 C- 2 C in FIG. 2;
- FIG. 3 is a perspective view of the present invention in the form of an alternate spinal disc implant
- FIG. 3A is a plan view of the posterior end of the implant of FIG. 3 taken along lines 3 A- 3 A in FIG. 3;
- FIG. 3B is a cross sectional view of the implant of FIG. 3 taken along the lines of 3 B- 3 B if FIG. 3A;
- FIG. 4 is a schematic top plan view of a human cervical vertebra with an implanted spinal disc implant of FIG. 1 indicated in solid lines.
- the artificial bone graft implant of the present invention has two basic portions, each composed of a biocompatible microporous material.
- a first portion is a core element and a second portion is a shell element that partially surrounds, and is bonded with, the core element through an interface region.
- the core is formed of a highly porous composition which allows for bone ingrowth and the shell is formed of a low porosity dense composition which provides for mechanical strength. This results in the average pore size of the core being greater than the average pore size of the shell. Also, the percent porosity of the core will be greater that the percent porosity of the shell.
- the interface region connecting the two portions may have gradient pore sizes in which the gradient range goes from a large pore size adjacent the core element to a small pore size adjacent the shell element.
- the core element can be formed in any shape but in one preferred embodiment it is formed of two uniformly sized cores generally oblong in shape and spaced apart from each other. A second preferred embodiment has one core element generally rectangular in shape.
- the shell element can also have a porous coating on its outer surface to promote bone ingrowth over all or a portion of the shell element in addition to the highly porous core element.
- the shell element can be formed with a gradient of pore sizes rather than being formed of a unitary low porosity dense composition.
- a center portion of the shell element is of a dense or low porosity which gradually changes to a high porosity outside surface.
- the core element remains the same in this alternative embodiment.
- the inventive implant is made from a microporous material that, after surgical implantation, bonds to the natural bone of the patient to form a rigid structure.
- a microporous material that, after surgical implantation, bonds to the natural bone of the patient to form a rigid structure.
- Such material encompasses, but is not limited to, biocompatible metallics, ceramics (including hydroxylapatite), polymers, and composite materials consisting of phosphate(s), bioactive glass(es), and bioresorbable polymer(s).
- the implant is preferably made from a ceramic, most preferably a hydroxylapatite such as calcium hydroxylapatite, having a chemical formula Ca 10 (P0 4 ) 6 (OH) 2 , available from Smith & Nephew Richards, Inc, 1450 Brooks Road, Memphis, Tenn. 08116 U.S.A.
- Ca 10 (P0 4 ) 6 (OH) 2 available from Smith & Nephew Richards, Inc, 1450 Brooks Road, Memphis, Tenn
- the dense portion of the preferred hydroxylapatite implant can be formed by pressing the dry HAp powder which is followed by sintering.
- the amount of pressure required for the pressing is dictated by the shape of the implant, but is typically in the range of 1000 to 2000 psi (6.9 to 14.8 MPa).
- the pressure is used to consolidate the powder and maximize packing.
- the optimal sintering protocol is dependent on the size and shape of the green (unsintered) part.
- the sintering could, but does not necessarily, include simultaneous use of heat and isostatic pressure (HIP).
- Sintering atmospheres can include argon, nitrogen, air and vacuum.
- the porous portion of the preferred hydroxylapatite implant involves then addition of bubbling agents, such as hydrogen peroxide, to a HAp slurry. The slurry is then dried and sintered.
- the hybrid dense/high porosity structure of the inventive implant can be produced by a two-step process wherein the dense and highly porous portions are produced separately (as described above) then combined with the interface and sintered to produce the final hybrid implant.
- the hybrid dense/highly porous implant can be produced in a one-step process by injection molding a HAp slurry containing a binder that will burn out during sintering which will create the different porosity of the core and shell.
- the inventive implant can be formed of a unitary structure having a gradient of pore sizes.
- the preferred gradient consists of a dense or low porosity center which gradually changes to a high porosity outside surface.
- the average pore size of the highly porous region would range from 100 to 800 microns. Bone requires a minimum pore size before ingrowth can occur. The maximum size would be limited by the strength requirements of the implant.
- the percent porosity at which the implant structure is considered to have high porosity is generally between about 30% porosity (or 70% dense) to 40% porosity (or 60% dense) which would still allow the implant to maintain the required mechanical strength. However, the maximum amount of percent porosity would most likely need to be lower than 40% in order to maintain adequate strength of the implant structure.
- the artificial bone graft implant of the present invention can be formed in any desirable shape for use in surgical procedures requiring a bone graft implant, such as facial reconstruction, the repair of long bone defects, and spinal surgery.
- a bone graft implant such as facial reconstruction, the repair of long bone defects, and spinal surgery.
- spinal surgery bone graft implants are frequently used when a fusion is done as part of an intervertebral discectomy procedure. During the fusion procedure, the bone graft implant is inserted into the intervertebral space after the disc is removed.
- FIGS. 1 , 1 A-D An embodiment of the present invention as an artificial spinal disc implant 10 is illustrated in FIGS. 1 , 1 A-D.
- implant 10 has two opposed lateral surfaces 12 , 14 with an anterior end 16 that tapers toward a posterior end 18 .
- the implant includes a pair of high porosity inner cores or inserts 20 , 22 that extend between the opposed lateral surfaces 12 , 14 , a low porosity dense shell 24 surrounding the cores 20 , 22 , and a region of gradient porosity 26 can separate the cores 20 , 22 and shell 24 .
- the cores 20 , 22 are generally oblong in shape with curved end portions and are generally spaced equal-distant apart from each other and the outer surface of the opposed lateral surfaces 12 , 14 .
- FIGS. 2 , 2 A- 2 C A second embodiment of the invention as a femoral ring implant 10 A, is illustrated in FIGS. 2 , 2 A- 2 C.
- Implant 10 A has one central porous core 28 extending between the opposed. lateral surfaces 12 , 14 and a dense shell 30 .
- the central core 28 can be separated from the dense shell 30 by a region of gradient porosity 32 .
- the central core 28 is generally rectangular in shape but could also be generally oval in shape.
- the femoral ring implant 10 A can be used to repair long bones or it can be used as a spinal disc replacement such as implant 10 .
- implant 10 B The inventive implant formed of a unitary structure having a gradient of pore sizes is illustrated in FIGS. 3, 3A, 3 B as implant 10 B.
- Implant 10 B has a dense or low porosity center 32 between the opposed lateral surfaces 12 , 14 which gradually changes to a high porosity outer portion 34 , as shown in FIG. 3B.
- the implant 10 is illustrated in FIG. 4 as it would appear when implanted between two cervical spinal vertebrae V (with only one vertebrae being shown) as a replacement for a spinal disc.
- the implant is formed of HAp including the core, shell, and gradient regions.
- the implant may also be made of calcium phosphate or other microporous ceramics, polymers and composite materials.
- the dense HAp element has a mechanical strength sufficient to bear the loads normally experienced by natural bones, and a compressive strength similar to the natural bones of the body.
- the porous HAp core element allows for natural bone ingrowth which facilitates permanent fixation of the implant after implantation in natural bone.
Abstract
An artificial bone graft implant for use as a replacement for living bone material in surgical procedures requiring the use of bone graft material includes a body formed of a microporous material and configured to be implanted into a prepared site in a patient's bone tissue. The body has a center portion, an outer portion and a pair of opposed outer surfaces defining the body. The body has a small average pore size in the center portion that gradually changes to larger average pore size in the outer portion. The pore size of the center portion of the implant allows for a load bearing capacity similar to natural bone and the pore size of the outer portion of the implant allows for the ingrowth of bone tissue.
Description
- The present application is a continuation of application Ser. No. 09/718,968 filed Nov. 22, 2000, which is a divisional of application Ser. No. 08/940,660 filed Sep. 29, 1997, now U.S. Pat. No. 6,149,688, which is a continuation of application Ser. No. 08/473,658 filed Jun. 7, 1995, now abandoned.
- The present invention relates to artificial bone graph implants and more specifically to artificial bone graft implants constructed so as to allow bone ingrowth while maintaining a load-bearing strength similar to natural bone.
- There are numerous surgical situations in which bone grafts are used as part of the surgical procedure. For example, bone grafts are used in facial reconstruction, in repairing long bone defects, and in spinal surgery such as intervertebral discectomy and fusion in which a bone graft implant replaces a spinal disc in the intervertebral space.
- Bone used for bone graft implants is often removed from another portion of a patient's body, which is called an autograft. A significant advantage of using a patient's own bone is the avoidance of tissue rejection, but harvesting bone also has its shortcomings. There is a risk to the patient in having a second surgical procedure (bone harvesting) performed at a secondary site which can lead to infection or additional pain to the patient. Further, the bone harvesting site is weakened by the removal of the bone. Also, the bone graft implant may not be perfectly shaped which can cause misplacement of the implant. This can lead to slippage or absorption of the implant, or failure of the implant to fuse with the bone it is in contact with.
- Other options for a bone graft source is bone removed from cadavers, called allograft, or from an animal, called xenograft. While these kinds of bone grafts relieve the patient of having a secondary surgical site as a possible source of infection or pain, this option carries a high incidence of graft rejection and an increased risk of the transmission of communicable diseases.
- An alternative to using living bone graft implants is the use of a manufactured implant made of a synthetic material that is biologically compatible with the body. With varying success, several synthetic compositions and various geometries of such implants have been utilized. In some instances, the implanting surgery of such implants is accomplished without difficulty, but the results can be unsatisfactory because any minor dents or imperfections in the implant can cause poor bone-to-implant bonding or an implant having a very high porosity can collapse due to lack of mechanical strength. In other instances, the artificial implant requires a complex surgical procedure that is difficult to perform and may not lead Co correction of the problem again, because of the above discussed side effects or dislocation of the artificial implant. Presently, no fully satisfactory artificial implant is known that can be implanted with a relatively straightforward procedure.
- Considerable study has been devoted to the development of materials that can be used for medical implants, including load-bearing implants, while allowing ingrowth of new bone tissue into the implant. To be suitable for this use, the material must meet several criteria, namely biocompatibility, porosity which allows tissue ingrowth and a mechanical strength suitable to bearing loads expected of natural bone without greatly exceed the natural bone's stiffness.
- Several materials have been examined as potential implant materials including ceramics, such as hydroxylapatite, Ca10(P04)6(OH)2, hardened polymers and biocompatible metals. Hydroxylapatite (HAp) has been of particular interest because of its similarity to natural bone mineral, but it has only been used for low load bearing applications as pure porous HAp itself is relatively low in mechanical strength and may not serve as a good prosthetic material for high load bearing implants.
- Studies have been directed at improving the mechanical strength properties of an HAp material in order to render it suitable as a high load bearing prosthetic material. European patent EP 0577342A1 to Bonfield et al. discloses a sintered composite of HAp and a biocompatible glass based on CaO and P205 that may be used in dental and medical applications as a replacement for unmodified HAp. To date, improvements in the mechanical strength of HAp material has been achieved at the expense of its porosity. Upon densification necessary to achieve adequate load bearing strength, the HAp material has a porosity which is insufficient to provide the desired degree of bone ingrowth.
- In a study entitled “Dense/porous Layered Apatite Ceramics Prepared by HIP Post Sintering,”Materials Science, Vol. 8, No. 10, pp. 1203 (October, 1989), by Ioku et al., the preparation of layers of dense HAp and porous HAp from two different types of HAp powder is discussed. This structure is prepared by first densifying specially produced fine crystals of HAp with a post-sintering process employing hot isostatic pressing (HIP). Then a commercial, coarse HAp powder is molded in layers with the densified HAp. Despite its being of academic interest, this type of HAp structure is not suitable for fabrication into load bearing bone prosthetic device configurations in which natural bone ingrowth may be achieved because of its lack of strength. However, Ioku suggests that the addition of zirconia whiskers into the dense HAp layer might provide some of the toughness necessary for hard-tissue prosthetic applications.
- Still desired in the art is an artificial bone graft implant that is formed of a biocompatible mineral material similar to bone which possesses compressive strength close to that of natural bone while providing for in growth of bone tissue for permanent fixation.
- The present invention provides an artificial bone graft implant formed of a biocompatible mineral material which possesses compressive strength similar to that of natural bone and allows bone tissue ingrowth for permanent fixations. The artificial bone graft implant is used as a replacement for living bone material in surgical procedures requiring the use of bone graft material. The inventive implant has a body configured to be implanted into a prepared site in a patient's bone tissue, with the body having a pair of opposed outer surfaces defining the body. A first and a second porous portion form the body with the first and second porous portions having pores of different sizes such that time average pore size of the first porous portion is greater than the average pore size of the second porous portion. The first porous portion of the body is formed in the shape of a core, with the core being in contact with the opposed outer surfaces of the body, and the second porous portion of the body is formed in the shape of an outer shell. The pore size of the first porous portion of the implant allows for the ingrowth of bone tissue while the pore size of the second portion of the implant allows for a load bearing capacity similar to natural bone.
- As will subsequently be described, the unique hybrid structure of a dense outer shell and a porous core provides load bearing support while simultaneously allowing bone ingrowth. The implant of the invention may be readily implanted by established surgical procedures, with minimal need to alter known surgical procedures. The hybrid porous/dense construction of the implant ensures normal load bearing and support through the eventual ingrowth of bone tissue, and minimizes the likelihood of implant dislocation relative to adjacent bone tissue either during surgery or during the post-operative fusion process.
- A better understanding of the invention can be obtained when the detailed description of exemplary embodiments set forth below is reviewed in conjunction with the accompanying drawings, in which:
- FIG. 1 is a perspective view of the present invention in the form of a spinal disc implant;
- FIG. 1A is a plan view of the posterior end of the implant of FIG. 1 taken along
lines 1A-1A; - FIG. 1B is a cross sectional view of the implant of FIG. 1 taken along lines1B-1B in FIG. 1A;
- FIG. 1C is a cross sectional view of the implant of FIG. 1A; taken along
lines 1C-1C in FIG. 1; - FIG. 1D is a cross sectional view of the implant of FIG. 1 taken along lines1D-1D in FIG. 1A;
- FIG. 2 is a perspective view of the present invention in the form of a femoral ring implant;
- FIG. 2A is a plan view of the posterior end of the implant of FIG. 2 taken along
lines 2A-2A; - FIG. 2B is a cross sectional view of the implant of FIG. 2 taken along
lines 2B-2B in FIG. 2A; - FIG. 2C is a cross sectional view of the implant of FIG. 2 taken along
lines 2C-2C in FIG. 2; - FIG. 3 is a perspective view of the present invention in the form of an alternate spinal disc implant;
- FIG. 3A is a plan view of the posterior end of the implant of FIG. 3 taken along
lines 3A-3A in FIG. 3; - FIG. 3B is a cross sectional view of the implant of FIG. 3 taken along the lines of3B-3B if FIG. 3A; and
- FIG. 4 is a schematic top plan view of a human cervical vertebra with an implanted spinal disc implant of FIG. 1 indicated in solid lines.
- The artificial bone graft implant of the present invention has two basic portions, each composed of a biocompatible microporous material. A first portion is a core element and a second portion is a shell element that partially surrounds, and is bonded with, the core element through an interface region. The core is formed of a highly porous composition which allows for bone ingrowth and the shell is formed of a low porosity dense composition which provides for mechanical strength. This results in the average pore size of the core being greater than the average pore size of the shell. Also, the percent porosity of the core will be greater that the percent porosity of the shell. The interface region connecting the two portions may have gradient pore sizes in which the gradient range goes from a large pore size adjacent the core element to a small pore size adjacent the shell element. The core element can be formed in any shape but in one preferred embodiment it is formed of two uniformly sized cores generally oblong in shape and spaced apart from each other. A second preferred embodiment has one core element generally rectangular in shape.
- The shell element can also have a porous coating on its outer surface to promote bone ingrowth over all or a portion of the shell element in addition to the highly porous core element. Alternatively, the shell element can be formed with a gradient of pore sizes rather than being formed of a unitary low porosity dense composition. In this embodiment, a center portion of the shell element is of a dense or low porosity which gradually changes to a high porosity outside surface. The core element remains the same in this alternative embodiment.
- The inventive implant is made from a microporous material that, after surgical implantation, bonds to the natural bone of the patient to form a rigid structure. Such material encompasses, but is not limited to, biocompatible metallics, ceramics (including hydroxylapatite), polymers, and composite materials consisting of phosphate(s), bioactive glass(es), and bioresorbable polymer(s). The implant is preferably made from a ceramic, most preferably a hydroxylapatite such as calcium hydroxylapatite, having a chemical formula Ca10(P04)6(OH)2, available from Smith & Nephew Richards, Inc, 1450 Brooks Road, Memphis, Tenn. 08116 U.S.A. The use of such materials in implants is known in the art, see for example U.S. Pat. No. 4,863,476, whose disclosure is incorporated in its entirety by reference herein.
- The dense portion of the preferred hydroxylapatite implant can be formed by pressing the dry HAp powder which is followed by sintering. The amount of pressure required for the pressing is dictated by the shape of the implant, but is typically in the range of 1000 to 2000 psi (6.9 to 14.8 MPa). The pressure is used to consolidate the powder and maximize packing. The optimal sintering protocol is dependent on the size and shape of the green (unsintered) part. The sintering could, but does not necessarily, include simultaneous use of heat and isostatic pressure (HIP). Sintering atmospheres can include argon, nitrogen, air and vacuum. The porous portion of the preferred hydroxylapatite implant involves then addition of bubbling agents, such as hydrogen peroxide, to a HAp slurry. The slurry is then dried and sintered.
- The hybrid dense/high porosity structure of the inventive implant can be produced by a two-step process wherein the dense and highly porous portions are produced separately (as described above) then combined with the interface and sintered to produce the final hybrid implant.
- Alternatively, the hybrid dense/highly porous implant can be produced in a one-step process by injection molding a HAp slurry containing a binder that will burn out during sintering which will create the different porosity of the core and shell.
- In an alternative embodiment, the inventive implant can be formed of a unitary structure having a gradient of pore sizes. The preferred gradient consists of a dense or low porosity center which gradually changes to a high porosity outside surface. The average pore size of the highly porous region would range from 100 to 800 microns. Bone requires a minimum pore size before ingrowth can occur. The maximum size would be limited by the strength requirements of the implant. The percent porosity at which the implant structure is considered to have high porosity is generally between about 30% porosity (or 70% dense) to 40% porosity (or 60% dense) which would still allow the implant to maintain the required mechanical strength. However, the maximum amount of percent porosity would most likely need to be lower than 40% in order to maintain adequate strength of the implant structure.
- The artificial bone graft implant of the present invention can be formed in any desirable shape for use in surgical procedures requiring a bone graft implant, such as facial reconstruction, the repair of long bone defects, and spinal surgery. For example, in spinal surgery, bone graft implants are frequently used when a fusion is done as part of an intervertebral discectomy procedure. During the fusion procedure, the bone graft implant is inserted into the intervertebral space after the disc is removed.
- An embodiment of the present invention as an artificial
spinal disc implant 10 is illustrated in FIGS. 1, 1A-D. As shown,implant 10 has two opposed lateral surfaces 12, 14 with ananterior end 16 that tapers toward aposterior end 18. The implant includes a pair of high porosity inner cores or inserts 20, 22 that extend between the opposed lateral surfaces 12, 14, a low porositydense shell 24 surrounding thecores gradient porosity 26 can separate thecores shell 24. Thecores - A second embodiment of the invention as a
femoral ring implant 10A, is illustrated in FIGS. 2, 2A-2C.Implant 10A has one centralporous core 28 extending between the opposed.lateral surfaces dense shell 30. Thecentral core 28 can be separated from thedense shell 30 by a region ofgradient porosity 32. Thecentral core 28 is generally rectangular in shape but could also be generally oval in shape. Thefemoral ring implant 10A can be used to repair long bones or it can be used as a spinal disc replacement such asimplant 10. - The inventive implant formed of a unitary structure having a gradient of pore sizes is illustrated in FIGS. 3, 3A,3B as implant 10B. Implant 10B has a dense or
low porosity center 32 between the opposed lateral surfaces 12, 14 which gradually changes to a high porosityouter portion 34, as shown in FIG. 3B. - The
implant 10 is illustrated in FIG. 4 as it would appear when implanted between two cervical spinal vertebrae V (with only one vertebrae being shown) as a replacement for a spinal disc. - In the preferred embodiment of the artificial bone graft implant, the implant is formed of HAp including the core, shell, and gradient regions. The implant may also be made of calcium phosphate or other microporous ceramics, polymers and composite materials. The dense HAp element has a mechanical strength sufficient to bear the loads normally experienced by natural bones, and a compressive strength similar to the natural bones of the body. The porous HAp core element allows for natural bone ingrowth which facilitates permanent fixation of the implant after implantation in natural bone.
- Although particular embodiments of the invention have been described in detail for purposes of illustration, various modifications may be made without departing from the spirit and scope of the invention. Accordingly, the invention is not to be limited except as by the appended claims.
Claims (6)
1. A artificial bone graft implant for use as a replacement for living bone material in surgical procedures requiring the use of bone graft material, the implant comprising:
a body formed of a microporous material and configured to be implanted into a prepared site in a patient's bone tissue, said body having a center portion, an outer portion and a pair of opposed outer surfaces defining said body;
said body having a small average pore size in the center portion that gradually changes to larger average pore size in the outer portion, wherein the pore size of the center portion of the implant allows for a load bearing capacity similar to natural bone and the pore size of the outer portion of the implant allows for the ingrowth of bone tissue.
2. The implant of claim 1 , wherein the body is comprised of a biocompatible microporous material that bonds to bone.
3. The implant of claim 2 , wherein the biocompatible microporous material is selected from the group consisting of polymers, ceramics and composite materials.
4. The implant of claim 3 , wherein the composite material comprises calcium phosphate, bioactive glass, and bioresorbable polymers.
5. A bone implant for use as a replacement for living bone material comprising:
a body comprising a bioabsorbable material configured and shaped to be implanted into a prepared site in bone tissue, the body having a center portion, an outer portion and a pair of opposed outer surfaces defining the body;
the body having a relatively low average porosity in the center portion and gradually changing to a relatively high average porosity in the outer portion, wherein the pore size of the center portion provides for a load bearing capacity generally similar to material bone and the pore size of the outer portion permits ingrowth of bone tissue.
6. The implant as claimed in claim 5 , wherein the body is monolithically formed of a bioabsorbable material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/353,533 US20030120348A1 (en) | 1995-06-07 | 2003-01-29 | Artificial bone graft implant |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47365895A | 1995-06-07 | 1995-06-07 | |
US08/940,660 US6149688A (en) | 1995-06-07 | 1997-09-29 | Artificial bone graft implant |
US09/718,968 US6607557B1 (en) | 1995-06-07 | 2000-11-22 | Artificial bone graft implant |
US10/353,533 US20030120348A1 (en) | 1995-06-07 | 2003-01-29 | Artificial bone graft implant |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/718,968 Continuation US6607557B1 (en) | 1995-06-07 | 2000-11-22 | Artificial bone graft implant |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030120348A1 true US20030120348A1 (en) | 2003-06-26 |
Family
ID=23880468
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/940,660 Expired - Lifetime US6149688A (en) | 1995-06-07 | 1997-09-29 | Artificial bone graft implant |
US09/718,968 Expired - Fee Related US6607557B1 (en) | 1995-06-07 | 2000-11-22 | Artificial bone graft implant |
US10/353,533 Abandoned US20030120348A1 (en) | 1995-06-07 | 2003-01-29 | Artificial bone graft implant |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/940,660 Expired - Lifetime US6149688A (en) | 1995-06-07 | 1997-09-29 | Artificial bone graft implant |
US09/718,968 Expired - Fee Related US6607557B1 (en) | 1995-06-07 | 2000-11-22 | Artificial bone graft implant |
Country Status (1)
Country | Link |
---|---|
US (3) | US6149688A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070213827A1 (en) * | 2005-09-28 | 2007-09-13 | Arramon Yves P | Hardened calcium phosphate cement bone implants |
US20070270844A1 (en) * | 2004-11-03 | 2007-11-22 | The Regents Of The University Of Michigan | Biodegradable implant for intertransverse process fusion |
US20090182429A1 (en) * | 2008-01-16 | 2009-07-16 | Warsaw Orthopedic, Inc. | Total joint Replacement |
US8603183B2 (en) * | 2011-06-22 | 2013-12-10 | Shinn Jyh Ding | Bilayered bone graft device |
WO2014152113A3 (en) * | 2013-03-14 | 2014-12-24 | Prosidyan, Inc. | Bioactive porous composite bone graft implants |
WO2014152102A3 (en) * | 2013-03-14 | 2015-02-12 | Prosidyan, Inc. | Bioactive porous bone graft implants |
US9381274B2 (en) | 2013-03-14 | 2016-07-05 | Prosidyan, Inc. | Bone graft implants containing allograft |
US10500312B2 (en) | 2013-03-14 | 2019-12-10 | Prosidyan, Inc. | Bioactive porous bone graft compositions with collagen |
US11890202B2 (en) | 2007-06-20 | 2024-02-06 | 3Spine, Inc. | Spinal osteotomy |
Families Citing this family (114)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6149688A (en) * | 1995-06-07 | 2000-11-21 | Surgical Dynamics, Inc. | Artificial bone graft implant |
FR2767675B1 (en) * | 1997-08-26 | 1999-12-03 | Materiel Orthopedique En Abreg | INTERSOMATIC IMPLANT AND ANCILLARY OF PREPARATION SUITABLE FOR ALLOWING ITS POSITION |
AU766735B2 (en) * | 1998-09-15 | 2003-10-23 | Isotis N.V. | Osteoinduction |
JP3974276B2 (en) * | 1998-11-30 | 2007-09-12 | ペンタックス株式会社 | Method for producing ceramic composite and ceramic composite |
US7270705B2 (en) * | 1999-07-14 | 2007-09-18 | Jiin-Huey Chern Lin | Method of increasing working time of tetracalcium phosphate cement paste |
US7169373B2 (en) * | 1999-07-14 | 2007-01-30 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
US6840995B2 (en) * | 1999-07-14 | 2005-01-11 | Calcitec, Inc. | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US7094282B2 (en) * | 2000-07-13 | 2006-08-22 | Calcitec, Inc. | Calcium phosphate cement, use and preparation thereof |
US6458162B1 (en) | 1999-08-13 | 2002-10-01 | Vita Special Purpose Corporation | Composite shaped bodies and methods for their production and use |
US6530929B1 (en) | 1999-10-20 | 2003-03-11 | Sdgi Holdings, Inc. | Instruments for stabilization of bony structures |
US6379385B1 (en) * | 2000-01-06 | 2002-04-30 | Tutogen Medical Gmbh | Implant of bone matter |
US6632246B1 (en) * | 2000-03-14 | 2003-10-14 | Chondrosite, Llc | Cartilage repair plug |
US7169183B2 (en) * | 2000-03-14 | 2007-01-30 | Warsaw Orthopedic, Inc. | Vertebral implant for promoting arthrodesis of the spine |
US6572654B1 (en) * | 2000-10-04 | 2003-06-03 | Albert N. Santilli | Intervertebral spacer |
US6620332B2 (en) | 2001-01-25 | 2003-09-16 | Tecomet, Inc. | Method for making a mesh-and-plate surgical implant |
US6599322B1 (en) | 2001-01-25 | 2003-07-29 | Tecomet, Inc. | Method for producing undercut micro recesses in a surface, a surgical implant made thereby, and method for fixing an implant to bone |
US7018418B2 (en) | 2001-01-25 | 2006-03-28 | Tecomet, Inc. | Textured surface having undercut micro recesses in a surface |
US6673075B2 (en) * | 2001-02-23 | 2004-01-06 | Albert N. Santilli | Porous intervertebral spacer |
US20050177237A1 (en) * | 2001-04-12 | 2005-08-11 | Ben Shappley | Spinal cage insert, filler piece and method of manufacturing |
WO2002083194A1 (en) | 2001-04-12 | 2002-10-24 | Therics, Inc. | Method and apparatus for engineered regenerative biostructures |
CA2447683A1 (en) | 2001-04-16 | 2002-10-24 | James J. Cassidy | Dense/porous structures for use as bone substitutes |
US7695521B2 (en) * | 2001-05-01 | 2010-04-13 | Amedica Corporation | Hip prosthesis with monoblock ceramic acetabular cup |
US6846327B2 (en) * | 2001-05-01 | 2005-01-25 | Amedica Corporation | Radiolucent bone graft |
US7776085B2 (en) | 2001-05-01 | 2010-08-17 | Amedica Corporation | Knee prosthesis with ceramic tibial component |
US20120330420A1 (en) * | 2001-05-01 | 2012-12-27 | Amedica Corporation | Spinal fusion implants |
EP1408874B1 (en) | 2001-06-14 | 2012-08-08 | Amedica Corporation | Metal-ceramic composite articulation |
US20090234457A1 (en) * | 2001-06-29 | 2009-09-17 | The Regents Of The University Of California | Systems, devices and methods for treatment of intervertebral disorders |
AU2002318159A1 (en) | 2001-06-29 | 2003-03-03 | The Regents Of The University Of California | Biodegradable/bioactive nucleus pulposus implant and method for treating degenerated intervertebral discs |
GB0119652D0 (en) * | 2001-08-11 | 2001-10-03 | Stanmore Implants Worldwide | Surgical implant |
JP4394441B2 (en) * | 2001-10-02 | 2010-01-06 | レックス メディカル リミテッド パートナーシップ | Spinal implant |
PT1455689E (en) * | 2001-10-30 | 2007-05-31 | Eyeborn Proprietary Ltd | Orbital implant |
US7011684B2 (en) * | 2002-01-17 | 2006-03-14 | Concept Matrix, Llc | Intervertebral disk prosthesis |
US7063725B2 (en) * | 2002-10-21 | 2006-06-20 | Sdgi Holdings, Inc. | Systems and techniques for restoring and maintaining intervertebral anatomy |
US7125425B2 (en) * | 2002-10-21 | 2006-10-24 | Sdgi Holdings, Inc. | Systems and techniques for restoring and maintaining intervertebral anatomy |
EP1418013B1 (en) | 2002-11-08 | 2005-01-19 | Howmedica Osteonics Corp. | Laser-produced porous surface |
WO2004058098A2 (en) | 2002-12-17 | 2004-07-15 | Amedica Corporation | Total disc implant |
WO2004084742A1 (en) | 2003-03-24 | 2004-10-07 | Theken Surgical Llc | Spinal implant adjustment device |
WO2004089240A2 (en) | 2003-04-04 | 2004-10-21 | Theken Disc, Llc | Artificial disc prosthesis |
US7118705B2 (en) * | 2003-08-05 | 2006-10-10 | Calcitec, Inc. | Method for making a molded calcium phosphate article |
US7163651B2 (en) | 2004-02-19 | 2007-01-16 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
US6994726B2 (en) | 2004-05-25 | 2006-02-07 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
JP4215595B2 (en) * | 2003-08-21 | 2009-01-28 | 安正 赤川 | Implant fixing member and implant composite material |
US20050065607A1 (en) * | 2003-09-24 | 2005-03-24 | Gross Jeffrey M. | Assembled fusion implant |
SE525787C2 (en) * | 2003-09-24 | 2005-04-26 | Nobel Biocare Ab | Procedure and apparatus for dental installation |
US20050065613A1 (en) * | 2003-09-24 | 2005-03-24 | Gross Jeffrey M. | Reinforced fusion implant |
US7189263B2 (en) * | 2004-02-03 | 2007-03-13 | Vita Special Purpose Corporation | Biocompatible bone graft material |
WO2005079880A1 (en) * | 2004-02-19 | 2005-09-01 | Calcitec, Inc. | Methods for preparing medical implants from calcium phosphate cement and medical implants |
WO2005089827A1 (en) * | 2004-03-22 | 2005-09-29 | Agency For Science, Technology And Research | Method for obtaining graded pore structure in scaffolds for tissues and bone, and scaffolds with graded pore structure for tissue and bone |
US7833271B2 (en) * | 2004-05-04 | 2010-11-16 | Zimmer Spine, Inc. | Spinal implants with body and insert |
US7621952B2 (en) * | 2004-06-07 | 2009-11-24 | Dfine, Inc. | Implants and methods for treating bone |
US20060095138A1 (en) * | 2004-06-09 | 2006-05-04 | Csaba Truckai | Composites and methods for treating bone |
KR100750190B1 (en) | 2004-06-16 | 2007-08-31 | 요업기술원 | Effective bone filler and manufacturing methods thereof |
US9220595B2 (en) | 2004-06-23 | 2015-12-29 | Orthovita, Inc. | Shapeable bone graft substitute and instruments for delivery thereof |
US20060106459A1 (en) * | 2004-08-30 | 2006-05-18 | Csaba Truckai | Bone treatment systems and methods |
US7250550B2 (en) | 2004-10-22 | 2007-07-31 | Wright Medical Technology, Inc. | Synthetic bone substitute material |
US8048083B2 (en) * | 2004-11-05 | 2011-11-01 | Dfine, Inc. | Bone treatment systems and methods |
JP4796079B2 (en) * | 2005-02-01 | 2011-10-19 | オステオバイオロジクス・インコーポレーテッド | Method and apparatus for selectively adding bioactive agents to multiphase implants |
AU2005335471A1 (en) * | 2005-08-10 | 2007-02-15 | Synthes, Gmbh | Porous implant |
US8025903B2 (en) | 2005-09-09 | 2011-09-27 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
CA2619469C (en) | 2005-09-09 | 2015-03-03 | Wright Medical Technology, Inc. | Composite bone graft cement comprising calcium sulfate dihydrate and brushite |
US8728387B2 (en) | 2005-12-06 | 2014-05-20 | Howmedica Osteonics Corp. | Laser-produced porous surface |
US10524916B2 (en) | 2006-01-11 | 2020-01-07 | Novabone Products, Llc | Resorbable macroporous bioactive glass scaffold and method of manufacture |
US20070233250A1 (en) * | 2006-02-07 | 2007-10-04 | Shadduck John H | Systems for treating bone |
US8252058B2 (en) | 2006-02-16 | 2012-08-28 | Amedica Corporation | Spinal implant with elliptical articulatory interface |
US8303967B2 (en) | 2006-06-29 | 2012-11-06 | Orthovita, Inc. | Bioactive bone graft substitute |
KR100743182B1 (en) * | 2006-09-11 | 2007-07-27 | 주식회사 메가젠 | Bone filler and method for fabricating the same |
US9403213B2 (en) * | 2006-11-13 | 2016-08-02 | Howmedica Osteonics Corp. | Preparation of formed orthopedic articles |
EP2086472B1 (en) | 2006-11-16 | 2019-06-12 | Rex Medical, L.P. | Spinal implant |
US20100256773A1 (en) * | 2007-07-03 | 2010-10-07 | Vlaamse Instelling Voor Technologisch Onderzoek N.V. (Vito) | Surgical implant composed of a porous core and a dense surface layer |
US8663326B2 (en) | 2007-12-13 | 2014-03-04 | Said G. Osman | Biologic artificial bone |
US9445854B2 (en) | 2008-02-01 | 2016-09-20 | Dfine, Inc. | Bone treatment systems and methods |
EP2252336B1 (en) | 2008-02-28 | 2014-06-25 | Dfine, Inc. | Bone treatment systems and methods |
EP2273952B1 (en) | 2008-04-02 | 2018-02-21 | Pioneer Surgical Technology, Inc. | Intervertebral implant devices for supporting vertebrae and devices for insertion thereof |
JP2011521697A (en) * | 2008-05-30 | 2011-07-28 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Implantable connection device |
US20100256758A1 (en) * | 2009-04-02 | 2010-10-07 | Synvasive Technology, Inc. | Monolithic orthopedic implant with an articular finished surface |
US8556972B2 (en) * | 2009-04-02 | 2013-10-15 | Sevika Holding AG | Monolithic orthopedic implant with an articular finished surface |
EP2263991A1 (en) | 2009-06-19 | 2010-12-22 | Nobel Biocare Services AG | Dental application coating |
US9775721B2 (en) | 2009-07-10 | 2017-10-03 | Bio2 Technologies, Inc. | Resorbable interbody device |
EP2453937A2 (en) * | 2009-07-14 | 2012-05-23 | Doctor's Research Group, Inc. | Multi-density polymeric interbody spacer and method for fabrication thereof |
US20110015743A1 (en) * | 2009-07-14 | 2011-01-20 | Doctors Research Group, Inc. | Multi-density polymeric interbody spacer |
US20110012280A1 (en) * | 2009-07-14 | 2011-01-20 | Doctors Research Group, Inc. | Method for fabricating a multi-density polymeric interbody spacer |
JP2011056052A (en) * | 2009-09-10 | 2011-03-24 | Olympus Terumo Biomaterials Corp | Bone prosthetic material |
WO2012048755A1 (en) | 2010-10-15 | 2012-04-19 | Université Libre de Bruxelles | Er-alpha-17p peptide, effects on stem cell differentiation |
US10569479B2 (en) | 2012-08-21 | 2020-02-25 | Vertera, Inc. | Systems and methods for making porous films, fibers, spheres, and other articles |
US9517136B2 (en) | 2013-03-15 | 2016-12-13 | Amedica Corporation | Variable-density implants and related methods and systems |
US9649197B2 (en) | 2013-03-15 | 2017-05-16 | Amedica Corporation | Thin-walled implant structures and related methods |
WO2015017324A1 (en) * | 2013-08-02 | 2015-02-05 | Bi02 Technologies, Inc. | Resorbable interbody device |
US9295565B2 (en) | 2013-10-18 | 2016-03-29 | Spine Wave, Inc. | Method of expanding an intradiscal space and providing an osteoconductive path during expansion |
CA2882468A1 (en) | 2014-02-19 | 2015-08-19 | Samin Eftekhari | Artificial bone nanocomposite and method of manufacture |
US20150366668A1 (en) * | 2014-06-23 | 2015-12-24 | Community Blood Center | Cellular-scale surface modification for increased osteogenic protein expression |
US9498922B2 (en) | 2014-06-26 | 2016-11-22 | Vertera, Inc. | Apparatus and process for producing porous devices |
US9504550B2 (en) | 2014-06-26 | 2016-11-29 | Vertera, Inc. | Porous devices and processes for producing same |
US10420597B2 (en) | 2014-12-16 | 2019-09-24 | Arthrex, Inc. | Surgical implant with porous region |
US11666445B2 (en) * | 2015-03-20 | 2023-06-06 | The Board Of Trustees Of The Leland Stanford Junior University | Customized load-bearing and bioactive functionally-graded implant for treatment of osteonecrosis |
WO2016154063A1 (en) * | 2015-03-20 | 2016-09-29 | The Board Of Trustees Of The Leland Stanford Junior Univeristy | Customized load-bearing and bioactive functionally-graded implant for treatment of osteonecrosis |
WO2016172026A1 (en) | 2015-04-20 | 2016-10-27 | The Board Of Regents Of The University Of Texas System | Clec11a is a bone growth agent |
USD815281S1 (en) | 2015-06-23 | 2018-04-10 | Vertera, Inc. | Cervical interbody fusion device |
WO2017192632A1 (en) | 2016-05-03 | 2017-11-09 | Additive Orthopaedics, LLC | Bone fixation device and method of use |
WO2017210695A1 (en) | 2016-06-03 | 2017-12-07 | Additive Orthopaedics, LLC | Bone fixation devices |
US20200000595A1 (en) | 2016-06-07 | 2020-01-02 | HD LifeSciences LLC | High X-Ray Lucency Lattice Structures |
US20180228612A1 (en) | 2017-02-14 | 2018-08-16 | HD LifeSciences LLC | High X-Ray Lucency Lattice Structures |
KR102606691B1 (en) * | 2016-06-08 | 2023-11-28 | 주식회사 코렌텍 | Artificial Joints with Porous Layers and Molding Method thereof |
WO2018023131A1 (en) | 2016-07-29 | 2018-02-01 | Additive Orthopaedics, LLC | Bone fixation device and method of use |
CN110099700A (en) * | 2016-10-05 | 2019-08-06 | 博纳雷务生物材料公司 | Bone implant |
US10695184B2 (en) | 2017-04-01 | 2020-06-30 | HD LifeSciences LLC | Methods of designing three-dimensional lattice structures for implants |
EP3606473A4 (en) * | 2017-04-01 | 2020-12-30 | HD Lifesciences LLC | Fluid interface system for implants |
JP2020533070A (en) | 2017-09-08 | 2020-11-19 | パイオニア サージカル テクノロジー インコーポレイテッド | Intervertebral implants, instruments, and methods |
USD907771S1 (en) | 2017-10-09 | 2021-01-12 | Pioneer Surgical Technology, Inc. | Intervertebral implant |
US11147679B2 (en) | 2018-02-05 | 2021-10-19 | Paragon Advanced Technologies, Inc. | Bone fixation device |
WO2020023938A1 (en) | 2018-07-26 | 2020-01-30 | HD LifeSciences LLC | Dynamic implant fixation plate |
US11065126B2 (en) | 2018-08-09 | 2021-07-20 | Stryker European Operations Holdings Llc | Interbody implants and optimization features thereof |
KR102276963B1 (en) * | 2018-12-28 | 2021-07-14 | 세종대학교산학협력단 | Implants With Multi Porous Structure And Manufacturing Method Thereof |
US11497617B2 (en) | 2019-01-16 | 2022-11-15 | Nanohive Medical Llc | Variable depth implants |
CN113811266A (en) * | 2019-03-12 | 2021-12-17 | 哈佩脊椎有限责任公司 | Implantable medical device having a thermoplastic composite and method for forming a thermoplastic composite |
Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US515791A (en) * | 1894-03-06 | Fruit cutter and press | ||
US576897A (en) * | 1897-02-09 | Billiard-cue chalker | ||
US3314420A (en) * | 1961-10-23 | 1967-04-18 | Haeger Potteries Inc | Prosthetic parts and methods of making the same |
US3867728A (en) * | 1971-12-30 | 1975-02-25 | Cutter Lab | Prosthesis for spinal repair |
US4007494A (en) * | 1975-04-11 | 1977-02-15 | Glasrock Products, Inc. | Bone cap |
US4156943A (en) * | 1977-08-24 | 1979-06-05 | Collier John P | High-strength porous prosthetic device and process for making the same |
US4164794A (en) * | 1977-04-14 | 1979-08-21 | Union Carbide Corporation | Prosthetic devices having coatings of selected porous bioengineering thermoplastics |
US4351069A (en) * | 1979-06-29 | 1982-09-28 | Union Carbide Corporation | Prosthetic devices having sintered thermoplastic coatings with a porosity gradient |
US4542539A (en) * | 1982-03-12 | 1985-09-24 | Artech Corp. | Surgical implant having a graded porous coating |
US4629464A (en) * | 1984-09-25 | 1986-12-16 | Tdk Corporation | Porous hydroxyapatite material for artificial bone substitute |
US4756862A (en) * | 1977-04-14 | 1988-07-12 | Amoco Corporation | Prosthetic devices having coatings of selected porous bioengineering thermoplastics |
US4863472A (en) * | 1986-09-05 | 1989-09-05 | Biocon Oy | Bone graft implant |
US4911720A (en) * | 1983-03-10 | 1990-03-27 | Collier John P | Particular surface replacement prosthesis |
US4969906A (en) * | 1987-07-28 | 1990-11-13 | Kronman Joseph H | Bone and bony tissue replacement |
US5049074A (en) * | 1989-03-29 | 1991-09-17 | Sugio Otani | Dental implant |
US5141510A (en) * | 1988-05-27 | 1992-08-25 | Shigehide Takagi | Structure of artificial bone material for use in implantation |
US5171720A (en) * | 1988-09-20 | 1992-12-15 | Asahi Kogaku Kogyo K.K. | Porous ceramic sinter and process for producing same |
US5215941A (en) * | 1989-11-10 | 1993-06-01 | Asahi Kogaku Kogyo K.K. | Process for producing a sintered apatite article having a porous surface using an acidic buffer solution |
US5236985A (en) * | 1990-09-07 | 1993-08-17 | Sumitomo Electric Industries Ltd. | Flame-retardant resin composition and insulated electrical wire employing the same |
US5258043A (en) * | 1987-07-20 | 1993-11-02 | Regen Corporation | Method for making a prosthetic intervertebral disc |
US5279831A (en) * | 1990-04-05 | 1994-01-18 | Norian Corporation | Hydroxyapatite prosthesis coatings |
US5306307A (en) * | 1991-07-22 | 1994-04-26 | Calcitek, Inc. | Spinal disk implant |
US5506308A (en) * | 1995-04-11 | 1996-04-09 | Interface, Inc. | Precure retardation of free radical cured elastomers |
US5507823A (en) * | 1993-12-28 | 1996-04-16 | Walston; D. Kenneth | Joint prosthesis having PTFE cushion |
US5531794A (en) * | 1993-09-13 | 1996-07-02 | Asahi Kogaku Kogyo Kabushiki Kaisha | Ceramic device providing an environment for the promotion and formation of new bone |
US5741330A (en) * | 1990-10-31 | 1998-04-21 | Baxter International, Inc. | Close vascularization implant material |
US6149688A (en) * | 1995-06-07 | 2000-11-21 | Surgical Dynamics, Inc. | Artificial bone graft implant |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE8912648U1 (en) * | 1989-10-23 | 1990-11-22 | Mecron Medizinische Produkte Gmbh, 1000 Berlin, De | |
US5152791A (en) * | 1989-12-07 | 1992-10-06 | Olympus Optical Co., Ltd. | Prosthetic artificial bone having ceramic layers of different porosity |
US5769897A (en) * | 1991-12-13 | 1998-06-23 | Haerle; Anton | Synthetic bone |
US5306309A (en) * | 1992-05-04 | 1994-04-26 | Calcitek, Inc. | Spinal disk implant and implantation kit |
GB9213774D0 (en) * | 1992-06-29 | 1992-08-12 | Queen Mary & Westfield College | Sintered hydroxyapatite compositions and method for the preparation thereof |
FR2697243A1 (en) * | 1992-10-26 | 1994-04-29 | Commissariat Energie Atomique | Process for the preparation of microporous calcium phosphate parts comprising hydroxylapatite, with controlled microporosity, and parts obtained by this process. |
DE9216092U1 (en) * | 1992-11-26 | 1993-01-14 | S + G Implants Gmbh, 2400 Luebeck, De |
-
1997
- 1997-09-29 US US08/940,660 patent/US6149688A/en not_active Expired - Lifetime
-
2000
- 2000-11-22 US US09/718,968 patent/US6607557B1/en not_active Expired - Fee Related
-
2003
- 2003-01-29 US US10/353,533 patent/US20030120348A1/en not_active Abandoned
Patent Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US576897A (en) * | 1897-02-09 | Billiard-cue chalker | ||
US515791A (en) * | 1894-03-06 | Fruit cutter and press | ||
US3314420A (en) * | 1961-10-23 | 1967-04-18 | Haeger Potteries Inc | Prosthetic parts and methods of making the same |
US3867728A (en) * | 1971-12-30 | 1975-02-25 | Cutter Lab | Prosthesis for spinal repair |
US4007494A (en) * | 1975-04-11 | 1977-02-15 | Glasrock Products, Inc. | Bone cap |
US4756862A (en) * | 1977-04-14 | 1988-07-12 | Amoco Corporation | Prosthetic devices having coatings of selected porous bioengineering thermoplastics |
US4164794A (en) * | 1977-04-14 | 1979-08-21 | Union Carbide Corporation | Prosthetic devices having coatings of selected porous bioengineering thermoplastics |
US4156943A (en) * | 1977-08-24 | 1979-06-05 | Collier John P | High-strength porous prosthetic device and process for making the same |
US4351069A (en) * | 1979-06-29 | 1982-09-28 | Union Carbide Corporation | Prosthetic devices having sintered thermoplastic coatings with a porosity gradient |
US4542539A (en) * | 1982-03-12 | 1985-09-24 | Artech Corp. | Surgical implant having a graded porous coating |
US4911720A (en) * | 1983-03-10 | 1990-03-27 | Collier John P | Particular surface replacement prosthesis |
US4629464A (en) * | 1984-09-25 | 1986-12-16 | Tdk Corporation | Porous hydroxyapatite material for artificial bone substitute |
US4863472A (en) * | 1986-09-05 | 1989-09-05 | Biocon Oy | Bone graft implant |
US5258043A (en) * | 1987-07-20 | 1993-11-02 | Regen Corporation | Method for making a prosthetic intervertebral disc |
US4969906A (en) * | 1987-07-28 | 1990-11-13 | Kronman Joseph H | Bone and bony tissue replacement |
US5141510A (en) * | 1988-05-27 | 1992-08-25 | Shigehide Takagi | Structure of artificial bone material for use in implantation |
US5171720A (en) * | 1988-09-20 | 1992-12-15 | Asahi Kogaku Kogyo K.K. | Porous ceramic sinter and process for producing same |
US5049074A (en) * | 1989-03-29 | 1991-09-17 | Sugio Otani | Dental implant |
US5215941A (en) * | 1989-11-10 | 1993-06-01 | Asahi Kogaku Kogyo K.K. | Process for producing a sintered apatite article having a porous surface using an acidic buffer solution |
US5279831A (en) * | 1990-04-05 | 1994-01-18 | Norian Corporation | Hydroxyapatite prosthesis coatings |
US5236985A (en) * | 1990-09-07 | 1993-08-17 | Sumitomo Electric Industries Ltd. | Flame-retardant resin composition and insulated electrical wire employing the same |
US5741330A (en) * | 1990-10-31 | 1998-04-21 | Baxter International, Inc. | Close vascularization implant material |
US5306307A (en) * | 1991-07-22 | 1994-04-26 | Calcitek, Inc. | Spinal disk implant |
US5531794A (en) * | 1993-09-13 | 1996-07-02 | Asahi Kogaku Kogyo Kabushiki Kaisha | Ceramic device providing an environment for the promotion and formation of new bone |
US5507823A (en) * | 1993-12-28 | 1996-04-16 | Walston; D. Kenneth | Joint prosthesis having PTFE cushion |
US5506308A (en) * | 1995-04-11 | 1996-04-09 | Interface, Inc. | Precure retardation of free radical cured elastomers |
US6149688A (en) * | 1995-06-07 | 2000-11-21 | Surgical Dynamics, Inc. | Artificial bone graft implant |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9724205B2 (en) * | 2004-11-03 | 2017-08-08 | The Regents Of The University Of Michigan | Biodegradable implant for intertransverse process fusion |
US20070270844A1 (en) * | 2004-11-03 | 2007-11-22 | The Regents Of The University Of Michigan | Biodegradable implant for intertransverse process fusion |
US20070213827A1 (en) * | 2005-09-28 | 2007-09-13 | Arramon Yves P | Hardened calcium phosphate cement bone implants |
US11890202B2 (en) | 2007-06-20 | 2024-02-06 | 3Spine, Inc. | Spinal osteotomy |
US20090182429A1 (en) * | 2008-01-16 | 2009-07-16 | Warsaw Orthopedic, Inc. | Total joint Replacement |
US8118873B2 (en) | 2008-01-16 | 2012-02-21 | Warsaw Orthopedic, Inc. | Total joint replacement |
US8603183B2 (en) * | 2011-06-22 | 2013-12-10 | Shinn Jyh Ding | Bilayered bone graft device |
CN105246519A (en) * | 2013-03-14 | 2016-01-13 | 普罗斯蒂安公司 | Bioactive porous bone graft implants |
CN105246518A (en) * | 2013-03-14 | 2016-01-13 | 普罗斯蒂安公司 | Bioactive porous composite bone graft implants |
JP2016515028A (en) * | 2013-03-14 | 2016-05-26 | プロシディアン,インコーポレーテッド | Bioactive porous bone graft implant |
JP2016517319A (en) * | 2013-03-14 | 2016-06-16 | プロシディアン,インコーポレーテッド | Bioactive porous composite bone graft implant |
US9381274B2 (en) | 2013-03-14 | 2016-07-05 | Prosidyan, Inc. | Bone graft implants containing allograft |
WO2014152102A3 (en) * | 2013-03-14 | 2015-02-12 | Prosidyan, Inc. | Bioactive porous bone graft implants |
US10335516B2 (en) | 2013-03-14 | 2019-07-02 | Prosidyan, Inc. | Bioactive porous bone graft implants |
US10478528B2 (en) | 2013-03-14 | 2019-11-19 | Prosidyan, Inc. | Bone graft implants containing allograft |
US10500312B2 (en) | 2013-03-14 | 2019-12-10 | Prosidyan, Inc. | Bioactive porous bone graft compositions with collagen |
US11129925B2 (en) | 2013-03-14 | 2021-09-28 | Prosidyan, Inc. | Bioactive porous bone graft implants |
WO2014152113A3 (en) * | 2013-03-14 | 2014-12-24 | Prosidyan, Inc. | Bioactive porous composite bone graft implants |
Also Published As
Publication number | Publication date |
---|---|
US6149688A (en) | 2000-11-21 |
US6607557B1 (en) | 2003-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6607557B1 (en) | Artificial bone graft implant | |
US5769897A (en) | Synthetic bone | |
US8556972B2 (en) | Monolithic orthopedic implant with an articular finished surface | |
US5030233A (en) | Porous flexible metal fiber material for surgical implantation | |
CA2305430C (en) | Bone substitutes | |
AU2009343793B2 (en) | Monolithic orthopedic implant with an articular finished surface | |
EP2055267B1 (en) | Radiolucent bone graft | |
US4693721A (en) | Porous flexible metal fiber material for surgical implantation | |
US4454612A (en) | Prosthesis formation having solid and porous polymeric components | |
US20110257753A1 (en) | Implant having a convex surface surrounding a concave articular surface | |
US20050010304A1 (en) | Device and method for reconstruction of osseous skeletal defects | |
MXPA04009547A (en) | Surgical implant. | |
US6887278B2 (en) | Prosthetic implant having segmented flexible stem | |
US5217496A (en) | Implant and method of making it | |
WO2012003037A2 (en) | Convex concave implant | |
US5047056A (en) | Canine hip prosthesis | |
JPH09501064A (en) | Artificial bone and artificial bone transplantation method | |
Mohanty | Medical Applications of alumina ceramics | |
Homsy | Tissue-ingrowth implant fixation by a soft porous coating | |
Wang et al. | Biomechanical Study on Repairing Bone Defect with Composite of Bovine Bone Morphogenetic Protein and Hydroxyapatite | |
Wang et al. | Biomechanical Study on Repairing Bone Defect with Composite of Bovine Bone Morphogenetic Protein and Porous Hydroxyapatite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |